sudafed xylospray dex ninasprei, lahus
mcneil healthcare (ireland) limited - ksülometasoliin+dekspantenool - ninasprei, lahus - 1mg+50mg 1ml 10ml 1tk
froben suuloputuslahus
viatris healthcare limited - flurbiprofeen - suuloputuslahus - 2,5mg 1ml 160ml 1tk
mometasone cipla ninasprei, suspensioon
cipla (eu) limited - mometasoon - ninasprei, suspensioon - 50mcg 1annus 140annus 1tk
senstend
plethora pharma solutions limited - lidokaiin, prilocaine - enneaegne ejakulatsioon - anesteetikumid - senstend on näidustatud ravi esmase enneaegne ejakulatsioon täiskasvanud mehed.
sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , kolmekordne kombineeritud ravi) lisandina toitumise ja treeningu patsientidel, ebapiisavalt kontrollitud nende maksimaalne talutav annus metformiin ja sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
nuedexta
jenson pharmaceutical services limited - dekstrometorfaan, kinidiin - neuro-käitumishäired - muud närvisüsteemi ravimid - nuedexta on näidustatud pseudobulbaarhaiguse (pba) sümptomaatiliseks raviks täiskasvanutel. efektiivsust on uuritud ainult amüotroofse lateraalskleroosi või hulgiskleroosi all kannatavatel patsientidel.
brufen kihisevad graanulid
viatris healthcare limited - ibuprofeen - kihisevad graanulid - 600mg 50tk; 600mg 40tk; 600mg 10tk; 600mg 30tk; 600mg 20tk
imatinib ranbaxy 100 mg õhukese polümeerikattega tablett
ranbaxy (u.k.) limited - imatiniib - õhukese polümeerikattega tablett - 100mg 90tk; 100mg 30tk; 100mg 60tk; 100mg 120tk; 100mg 100tk
imatinib ranbaxy 400 mg õhukese polümeerikattega tablett
ranbaxy (u.k.) limited - imatiniib - õhukese polümeerikattega tablett - 400mg 30tk; 400mg 60tk; 400mg 120tk
brufen toimeainet prolongeeritult vabastav tablett
viatris healthcare limited - ibuprofeen - toimeainet prolongeeritult vabastav tablett - 800mg 30tk